Bank of New York Mellon
PRNB

Bank of New York Mellon’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bank of New York Mellon’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-108,266
Closed -$6.47M – 4176
2020
Q2 		$6.47M Buy
108,266
+15,344
+17% +$948K ﹤0.01% 2078
2020
Q1 		$5.52M Buy
92,922
+8,616
+10% +$502K ﹤0.01% 2030
2019
Q4 		$4.62M Buy
84,306
+39,645
+89% +$1.48M ﹤0.01% 2382
2019
Q3 		$1.26M Sell
44,661
-335
-0.7% -$12.3K ﹤0.01% 3033
2019
Q2 		$1.49M Buy
44,996
+26,087
+138% +$814K ﹤0.01% 2975
2019
Q1 		$642K Buy
+18,909
New +$601K ﹤0.01% 3427

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Bank of New York Mellon's PRNB Position: Q3 2020 in Review

Bank of New York Mellon sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 108,266 shares — an estimated $6.47M sold.

Bank of New York Mellon first reported a position in PRNB in Q1 2019 and held it in 6 quarters. The position peaked at $6.47M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Bank of New York Mellon reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Bank of New York Mellon sold 108,266 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $6.47M.
  • Bank of New York Mellon first reported a position in Principia Biopharma Inc. Common Stock in Q1 2019 and held it in 6 quarters.
  • Bank of New York Mellon's Principia Biopharma Inc. Common Stock position peaked at $6.47M in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Bank of New York Mellon's 13F filing for Q3 2020, filed 12 Nov 2020.